Chiesi Nordic Revenue and Competitors

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Chiesi Nordic's estimated annual revenue is currently $19.7M per year.(i)
  • Chiesi Nordic's estimated revenue per employee is $201,000

Employee Data

  • Chiesi Nordic has 98 Employees.(i)
  • Chiesi Nordic grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.7M985%N/AN/A
Add Company

What Is Chiesi Nordic?

Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.

keywords:N/A

N/A

Total Funding

98

Number of Employees

$19.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.6M9811%N/A
#2
$13.7M981%N/A
#3
$21.6M98-4%N/A
#4
$20.1M9817%N/A
#5
$32.5M9921%N/A